Key result
Corticosteroids rapidly restore systolic function in a pediatric rheumatic myopericarditis case with 25% initial LVEF.
Why the study?
In regions endemic for acute rheumatic fever, suspicion of myocarditis origin must also be directed toward rheumatic etiology.
Does corticosteroid therapy improve systolic function in a pediatric patient with rheumatic myopericarditis?
Does corticosteroid therapy improve systolic function in a pediatric patient with rheumatic myopericarditis?
Corticosteroid therapy may lead to rapid recovery of systolic function in pediatric patients with rheumatic myopericarditis.
Corticosteroids may enable rapid systolic recovery in pediatric rheumatic myopericarditis; leaves open confirmation in prospective trials.
In an endemic region for acute rheumatic fever, the suspicion of myocarditis origin had also to be directed into rheumatic etiology. We present a case of a 10-year-old patient with subacute fever and myocardial systolic dysfunction (ejection fraction: 25%). One week after treatment, recovery of systolic function was observed.
No takes yet. Share an insight, caveat, or question.
Hendiperdana et al. (2024) studied this question. Corticosteroid therapy restored systolic function within one week in a 10-year-old pediatric patient with rheumatic myopericarditis and an initial ejection fraction of 25%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: